Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Almstetter is active.

Publication


Featured researches published by Michael Almstetter.


Journal of Chemical Information and Modeling | 2006

COSMO s im : Bioisosteric Similarity Based on COSMO-RS sigma Profiles.

Michael Thormann; Andreas Klamt; Martin Hornig; Michael Almstetter

A novel approach for the quantification of drug similarity is proposed, which makes use of the surface polarities, that is, conductor surface polarization charge densities sigma, as defined in the quantum chemically based conductor-like screening model for realistic solvation(COSMO-RS). The histogram of these surface polarities, the so-called sigma profiles, have been proven to be the key for the calculation of all kinds of partition and adsorption coefficients and, therefore, of relevant absorption, distribution, metabolism, and excretion parameters such as solubility, pKa, log BB, and many others. They also carry a large part of the information required for the estimation of desolvation and binding processes responsible for receptor binding and enzyme inhibition of drug molecules. Thus, a large degree of similarity with respect to the sigma profiles appears to be a necessary condition for drugs of similar physiological action. Driven by this insight, we propose a sigma-profile-based drug similarity measure COSMOsim for the detection of new bioisosteric drug candidates. In several examples, we demonstrate its statistical and pharmaceutical plausibility, its practicability for real drug research projects, and its unique independence from the chemical structure, which enables scaffold hopping in a natural way.


The Open Applied Informatics Journal | 2007

Nomen Est Omen: Quantitative Prediction of Molecular Properties Directly from IUPAC Names

Michael Thormann; David Vidal; Michael Almstetter; Miquel Pons

The International Union of Pure and Applied Chemistry (IUPAC) was formed in 1919 by chemists from indus- try and academia (1). Over nearly nine decades the Union has succeeded in fostering worldwide communications in the chemical sciences and in uniting chemistry - academic, industrial and government - in a common language. As one of the results of the Union, IUPAC names nowadays serve as a commonly agreed text representation of chemical structures in patents, publications and databases. In public databases of chemical compounds, like PubChem with more than 12 million entries, chemical structures are identified by default using their IUPAC names (2). We report a very fast linguistic method to extract the implicit information contained in IUPAC names to statistically predict pharmacologically relevant proper- ties. This provides an efficient annotation tool that can be used to assess the likelihood of a given compound as a drug candidate and renders the entire chemical literature a searchable database for virtual screening experiments and data mining.


Archive | 2002

Diversity in Very Large Libraries

Lutz Weber; Michael Almstetter

Combinatorial chemistry methods can be used, in principle, for the synthesis of very large compound libraries. However, these very large libraries are so large that the enumeration of all individual members of a library may not be practicable. We discuss here how one may increase the chances of finding compounds with desired properties from very large libraries by using combinatorial optimisation methods. Neuronal networks, evolutionary programming and especially genetic algorithms are heuristic optimisation methods that can be used implicitly to discover the relation between the structure of molecules and their properties. Genetic algorithms are derived from principles that are used by nature to find optimal solutions. Genetic algorithms have now been adapted and applied with success to problems in combinatorial chemistry. The optimisation behaviour of genetic algorithms was investigated using a library of molecules with known biological activities. From these studies, one can derive methods to estimate the diversity and structure property relationships without the need to enumerate and calculate the properties of the whole search space of these very large libraries.


Journal of Medicinal Chemistry | 2004

Crystal structures of Staphylococcus aureus methionine aminopeptidase complexed with keto heterocycle and aminoketone inhibitors reveal the formation of a tetrahedral intermediate

Alice Douangamath; Glenn E. Dale; Allan D'Arcy; Michael Almstetter; Robert Eckl; Annabelle Frutos-Hoener; Bernd Henkel; Katrin Illgen; Sven Nerdinger; Henk Schulz; Aengus Macsweeney; Michael Thormann; Andreas Treml; Sabine Pierau; Sjoerd Wadman; Christian Oefner


Archive | 2003

Methods and systems for discovery of chemical compounds and their syntheses

Michael Almstetter; Peter Zegar; Andreas Tremi; Michael Thormann; Lutz Weber


Archive | 2006

2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators

Robert Eckl; Roswitha Taube; Michael Almstetter; Michael Thormann; Andreas Treml; Christopher Sean Straub; Zhuoliang Chen


Archive | 2004

Novel bioisosteres of actinonin

Michael Thormann; Michael Almstetter


Archive | 2004

Bioisosteres of actinonin

Michael Thormann; Michael Almstetter


Archive | 2006

Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP)

Robert Eckl; Michael Almstetter; Roswitha Taube; Michael Thormann; Andreas Treml


Archive | 2004

Neue Bioisostere von Actinonin

Michael Thormann; Michael Almstetter

Collaboration


Dive into the Michael Almstetter's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andreas Klamt

University of Regensburg

View shared research outputs
Researchain Logo
Decentralizing Knowledge